Weiss, D., Dobkowitz, E., Prell, T., & Schönenberg, A. (2025). A Single-Item Measure of (Non)Essentialist Beliefs About Aging. GeroPsych, 0(0). https://doi.org/10.1024/1662-9647/a000355
Schönenberg, A., Prell, T. Health literacy as a buffer: mitigating the impact of Multimorbidity on functional health in older adults. Aging Clin Exp Res 37, 341 (2025). https://doi.org/10.1007/s40520-025-03259-2
Schönenberg, A., Kobus, C., Günther, M., Umfermann, L., & Prell, T. (2025). Perceptions of Aging and Control Beliefs: A Study on Older Patients’ Views of Aging. Geriatrics, 10(6), 148. https://doi.org/10.3390/geriatrics10060148
Küstner, A.L., Schönenberg, A., Prell, T. (2025). The association between boredom proneness, functional status, and views on ageing in geriatric patients. Front. Psychol., 16:1657437. https://doi.org/10.3389/fpsyg.2025.1657437
Schönenberg, A., Heimrich, K.G., Sternkopf, A., Lochbihler, P., Prell, T. (2025). Patient-reported geriatric syndromes and their association with quality of life: findings from a cross-sectional study in German older adults. Eur Geriatr Med. doi.org/10.1007/s41999-025-01332-7
Schwesig, R., Strutz, N., Schönenberg, A., Panian, M., Delank, K.-S., Laudner, K. G., & Prell, T. (2025). Quantifying Gait and Posture in Geriatric Inpatients Using Inertial Sensors and Posturography: A Cross-Sectional Study. Diagnostics, 15(20), 2578. doi.org/10.3390/diagnostics15202578
Heimrich, K.G., Schönenberg, A., Franke, G.H., Prell, T. (2025). Medication Adherence in Parkinson’s Disease: Longitudinal Changes and the Influence of Depressive Symptoms. Patient Prefer Adherence. 19:2835-2845. https://doi.org/10.2147/PPA.S529538
Schönenberg, A., Küstner, A. L., & Prell, T. (2025). Thinking it’s boring in old age increases risk for future loneliness: findings from the German Ageing Survey (DEAS). Aging & Mental Health, 1–11. doi.org/10.1080/13607863.2025.2545355
Mendorf, S., Heimrich, K. G., Mühlhammer, H. M., Prell, T. & Schönenberg, A. (2025). Age-related trajectories of quality of life in community dwelling older adults: findings from the Survey of Health, Aging and Retirement in Europe (SHARE). Frontiers in Aging Neuroscience 17, 10.3389/fnagi.2025.1632607
Wagner, A., Schönenberg, A., Prell, T. (2025). The Direct and Indirect Effects of Hearing Loss on Loneliness in Older Adults. Ear Hear. doi: 10.1097/AUD.0000000000001699
Heimrich, K.G., Schönenberg, A., Mendorf, S., Lehmann, T., Prell, T. (2025). Predictors of Functional Improvement During Comprehensive Geriatric Care in Germany: A 10-Year Monocentric Retrospective Analysis. Sage Open Aging 11. 10.1177/30495334251346941
Heimrich, K. G., Lemhöfer, C. & Prell, T. (2025). Die geriatrische Frührehabilitation. Rehabilitation 64, 176-184, 10.1055/a-2427-1414
Mendorf, S., Heimrich, K.G., Mühlhammer, H.M., Schönenberg, A., Prell, T. (2025) The influence of the Big Five inventory on quality of life in people with Parkinson’s disease aged 50 and above: A Longitudinal Analysis from the Survey of Health, Aging and Retirement in Europe (SHARE). PLOS ONE, 20(5): e0322089. https://doi.org/10.1371/journal.pone.0322089
Günther, M., Kobus, C., Perner, C., Schönenberg, A., & Prell, T. (2025). Chronic Pruritus in Geriatric Patients: Prevalence, Associated Factors, and Itch-related Quality of Life. Acta Dermato-Venereologica, 105, adv42003. https://doi.org/10.2340/actadv.v105.42003
Prell, T., & Axer, H. (2022). Avoidance Behavior in Patients with Chronic Dizziness: A Prospective Observational Study. Journal of clinical medicine, 11(24), 7473. https://doi.org/10.3390/jcm11247473
Prell, T., Schönenberg, A., Mendorf, S., Mühlhammer, H. M., Grosskreutz, J., & Teschner, U. (2022). Data on medication adherence in adults with neurological disorders: The NeuroGerAd study. Scientific data, 9(1), 734. https://doi.org/10.1038/s41597-022-01847-9
Schönenberg, A., Mühlhammer, H. M., Lehmann, T., & Prell, T. (2022). Adherence to Medication in Neurogeriatric Patients: Insights from the NeuroGerAd Study. Journal of clinical medicine, 11(18), 5353. https://doi.org/10.3390/jcm11185353
Schönenberg, A., Teschner, U., Prell, T., & Mühlhammer, H. M. (2022). Validation and Psychometric Analysis of the German Translation of the Appraisal of Self-Care Agency Scale-Revised. Healthcare (Basel, Switzerland), 10(9), 1785. https://doi.org/10.3390/healthcare10091785
Dieckmann, N., Roediger, A., Prell, T., Schuster, S., Herdick, M., Mayer, T. E., Witte, O. W., Steinbach, R., & Grosskreutz, J. (2022). Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness. NeuroImage. Clinical, 36, 103162. https://doi.org/10.1016/j.nicl.2022.103162
Heimrich, K. G., & Prell, T. (2022). Data on the effect of Parkinson's disease multimodal complex treatment in a German University Hospital. Data in brief, 44, 108496. https://doi.org/10.1016/j.dib.2022.108496
Prell, T., Mendorf, S., & Axer, H. (2022). Tolerance to Dizziness Intensity Increases With Age in People With Chronic Dizziness. Frontiers in neurology, 13, 934627. https://doi.org/10.3389/fneur.2022.934627
Mendorf, S., Prell, T., & Schönenberg, A. (2022). Detecting Reasons for Nonadherence to Medication in Adults with Epilepsy: A Review of Self-Report Measures and Key Predictors. Journal of clinical medicine, 11(15), 4308. https://doi.org/10.3390/jcm11154308
Heimrich, K. G., Prell, T., & Schönenberg, A. (2022). What Determines That Older Adults Feel Younger Than They Are? Results From a Nationally Representative Study in Germany. Frontiers in medicine, 9, 901420. https://doi.org/10.3389/fmed.2022.901420
Scholz, K., Geritz, J., Kudelka, J., Rogalski, M., Niemann, K., Maetzler, C., Welzel, J., Drey, M., Prell, T., & Maetzler, W. (2022). Static Balance and Chair-Rise Performance in Neurogeriatric Patients: Promising Short Physical Performance Battery-Derived Predictors of Fear of Falling. Frontiers in medicine, 9, 904364. https://doi.org/10.3389/fmed.2022.904364
Prell, T., Liebermann, J. D., Mendorf, S., & Zipprich, H. M. (2022). Data on pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study. Data in brief, 42, 108288. https://doi.org/10.1016/j.dib.2022.108288
Schönenberg, A., Zipprich, H. M., Teschner, U., & Prell, T. (2022). Impact of Depression, Resilience, and Locus of Control on Adjustment of Health-Related Expectations in Aging Individuals With Chronic Illness. Frontiers in psychology, 13, 867785. https://doi.org/10.3389/fpsyg.2022.867785
Prell, T., Franke, G. H., Jagla-Franke, M., & Schönenberg, A. (2022). Identifying Patterns of Self-Reported Nonadherence Using Network Analysis in a Mixed German Cohort. Patient preference and adherence, 16, 1153–1162. https://doi.org/10.2147/PPA.S362464
Prell, T., Finn, S.,Zipprich, H. M., & Axer, H. (2022). What Predicts Improvement of Dizziness after Multimodal and Interdisciplinary Day Care Treatment? Journal of clinical medicine, 11(7), 2005. https://doi.org/10.3390/jcm11072005
Schönenberg, A., & Prell, T. (2022). Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment. PloS one, 17(4), e0266140. https://doi.org/10.1371/journal.pone.0266140
Prell, T., Uhlig, M., Derlien, S., Maetzler, W., & Zipprich, H. M. (2022). Fear of Falling Does Not Influence Dual-Task Gait Costs in People with Parkinson's Disease: A Cross-Sectional Study. Sensors (Basel, Switzerland), 22(5), 2029. https://doi.org/10.3390/s22052029
Prell, T., Finn, S., & Axer, H. (2022). How Healthcare Utilization Due to Dizziness and Vertigo Differs Between Older and Younger Adults. Frontiers in medicine, 9, 852187. https://doi.org/10.3389/fmed.2022.852187
Schwarzkopf, A., Schönenberg, A., & Prell, T. (2022). Patterns and Predictors of Medication Change after Discharge from Hospital: An Observational Study in Older Adults with Neurological Disorders. Journal of clinical medicine, 11(3), 563. https://doi.org/10.3390/jcm11030563
Prell, T., Wassermann, A., Zipprich, H. M., Finn, S., & Axer, H. (2021). Impact of Common Dizziness Associated Symptoms on Dizziness Handicap in Older Adults. Frontiers in neurology, 12, 801499. https://doi.org/10.3389/fneur.2021.801499
Schönenberg, A., & Prell, T. (2021). Factors Influencing Self-Reported Medication Use in the Survey of Health Aging and Retirement in Europe (SHARE) Dataset. Healthcare, 9(12), 1752. https://doi.org/10.3390/healthcare9121752
Heimrich, K. G., & Prell, T. (2021). Short- and Long-Term Effect of Parkinson's Disease Multimodal Complex Treatment. Brain sciences, 11(11), 1460. https://doi.org/10.3390/brainsci11111460
Zipprich, H. M., Mendorf, S., Schönenberg, A., & Prell, T. (2021). The impact of poor medication knowledge on health-related quality of life in people with Parkinson's disease: a mediation analysis. Quality of life research, 31(5), 1473–1482. https://doi.org/10.1007/s11136-021-03024-8
Prell, T., Vlad, B., Gaur, N., Stubendorff, B., & Grosskreutz, J. (2021). Blood-Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis. Frontiers in neuroscience, 15, 656456. https://doi.org/10.3389/fnins.2021.656456
Prell, T., Liebermann, J. D., Mendorf, S., Lehmann, T., & Zipprich, H. M. (2021). Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study. PloS one, 16(11), e0257966. https://doi.org/10.1371/journal.pone.0257966
Schönenberg, A., Teschner, U., & Prell, T. (2021). Expectations and behaviour of older adults with neurological disorders regarding general practitioner consultations: an observational study. BMC geriatrics, 21(1), 512. https://doi.org/10.1186/s12877-021-02469-3
Gerland, H. E., & Prell, T. (2021). Association Between the Health Locus of Control and Medication Adherence: An Observational, Cross-Sectional Study in Primary Care. Frontiers in medicine, 8, 705202. https://doi.org/10.3389/fmed.2021.705202
Heimrich, K. G., Lehmann, T., Schlattmann, P., & Prell, T. (2021). Heart Rate Variability Analyses in Parkinson's Disease: A Systematic Review and Meta-Analysis. Brain sciences, 11(8), 959. https://doi.org/10.3390/brainsci11080959
Franke, G. H., Nentzl, J., Jagla-Franke, M., & Prell, T. (2021). Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study. Patient preference and adherence, 15, 1439–1449. https://doi.org/10.2147/PPA.S311946
Gaur, N., Huss, E., Prell, T., Steinbach, R., Guerra, J., Srivastava, A., Witte, O. W., & Grosskreutz, J. (2021). Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study. Frontiers in neurology, 12, 629332. https://doi.org/10.3389/fneur.2021.629332
Zipprich, H. M., & Prell, T. (2021). Difficulties in reporting purpose and dosage of prescribed medications are associated with poor cognition and depression. PloS one, 16(5), e0251374. https://doi.org/10.1371/journal.pone.0251374
Steinbach, R., Prell, T., Gaur, N., Roediger, A., Gaser, C., Mayer, T. E., Witte, O. W., & Grosskreutz, J. (2021). Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis. NeuroImage. Clinical, 30, 102674. https://doi.org/10.1016/j.nicl.2021.102674
Schönenberg, A., Zipprich, H. M., Teschner, U., Grosskreutz, J., Witte, O. W., & Prell, T. (2021). Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status. Health and quality of life outcomes, 19(1), 107. https://doi.org/10.1186/s12955-021-01753-5
Zipprich, H. M., Mendorf, S., Lehmann, T., & Prell, T. (2021). Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson's Disease. Brain sciences, 11(2), 273. https://doi.org/10.3390/brainsci11020273
Zipprich, H. M., Schönenberg, A., Teschner, U., & Prell, T. (2021). Changes of perceptions and behaviours during the phases of COVID-19 pandemic in German elderly people with neurological disorders: an observational study using telephone interviews. BMJ open, 11(1), e045780. https://doi.org/10.1136/bmjopen-2020-045780
Mendorf, S., Witte, O. W., Zipprich, H.M., & Prell, T. (2020). Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease. Frontiers in neurology, 11, 551696. https://doi.org/10.3389/fneur.2020.551696
Steinbach, R., Gaur, N., Roediger, A., Mayer, T. E., Witte, O. W., Prell, T., & Grosskreutz, J. (2021). Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Human brain mapping, 42(3), 737–752. https://doi.org/10.1002/hbm.25258
Steinbach, R., Prell, T., Gaur, N., Stubendorff, B., Roediger, A., Ilse, B., Witte, O. W., & Grosskreutz, J. (2020). Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model. Journal of clinical medicine, 9(9), 2873. https://doi.org/10.3390/jcm9092873
Prell, T., Grosskreutz, J., & Pooled Resource Open-Access ALS Clinical Trials Consortium (2020). Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials. PloS one, 15(8), e0237175. https://doi.org/10.1371/journal.pone.0237175
Prell, T., Siebecker, F., Lorrain, M., Tönges, L., Warnecke, T., Klucken, J., Wellach, I., Buhmann, C., Wolz, M., Lorenzl, S., Herbst, H., Eggers, C., & Mai, T. (2020). Specialized Staff for the Care of People with Parkinson's Disease in Germany: An Overview. Journal of clinical medicine, 9(8), 2581. https://doi.org/10.3390/jcm9082581
Feldmann, F., Zipprich, H. M., Witte, O. W., & Prell, T. (2020). Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease. Parkinson's disease, 2020, 4315489. https://doi.org/10.1155/2020/4315489
Liebermann, J. D., Witte, O. W., & Prell, T. (2020). Association between different coping styles and health-related quality of life in people with Parkinson's disease: a cross-sectional study. BMJ open, 10(7), e036870. https://doi.org/10.1136/bmjopen-2020-036870
Zipprich, H. M., Teschner, U., Witte, O. W., Schönenberg, A., & Prell, T. (2020). Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson's Disease in Germany. Journal of clinical medicine, 9(6), 1643. https://doi.org/10.3390/jcm9061643
Jacobs, A. H., Emmert, K., Baron, R., Bartsch, T., Bauer, J., Becker, C., Berg, D., Bergmann, P., Boetzel, K., Bollheimer, C., Deuschl, G., Djukic, M., Drey, M., Durwen, H., Ebersbach, G., Elshehabi, M., Geritz, J., Gisinger, C., Guennewig, T., Hauptmann, B., Prell, T.,… Maetzler, W. (2020). Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilities. Neurogeriatrie – eine Vision für die verbesserte Versorgung und Forschung für geriatrische Patienten mit führend neurologischen Erkrankungen. Zeitschrift fur Gerontologie und Geriatrie, 53(4), 340–346. https://doi.org/10.1007/s00391-020-01734-1
Prell, T., Teschner, U., Witte, O. W., & Kunze, A. (2020). Current and Desired Quality of Life in People with Parkinson's Disease: the Calman Gap Increases with Depression. Journal of clinical medicine, 9(5), 1496. https://doi.org/10.3390/jcm9051496
Prell, T., Siebecker, F., Lorrain, M., Eggers, C., Lorenzl, S., Klucken, J., Warnecke, T., Buhmann, C., Tönges, L., Ehret, R., Wellach, I., & Wolz, M. (2020). Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany. Journal of clinical medicine, 9(5), 1455. https://doi.org/10.3390/jcm9051455
Schijven, D., Stevelink, R., McCormack, M., van Rheenen, W., Luykx, J. J., Koeleman, B. P. C., Veldink, J. H., Project MinE ALS GWAS Consortium, & International League Against Epilepsy Consortium on Complex Epilepsies (2020). Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy. Neurobiology of aging, 92, 153.e1–153.e5. https://doi.org/10.1016/j.neurobiolaging.2020.04.011
Gruber, M. T., Witte, O. W., Grosskreutz, J., & Prell, T. (2020). Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study. PloS one, 15(5), e0232764. https://doi.org/10.1371/journal.pone.0232764
Prell, T., Gaur, N., Steinbach, R., Witte, O. W., & Grosskreutz, J. (2020). Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Health and quality of life outcomes, 18(1), 117. https://doi.org/10.1186/s12955-020-01372-6
Reichmann, H., Lees, A., Rocha, J. F., Magalhães, D., Soares-da-Silva, P., & OPTIPARK investigators (2020). Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Translational neurodegeneration, 9(1), 9. https://doi.org/10.1186/s40035-020-00187-1
Mendorf, S., Witte, O. W., Grosskreutz, J., Zipprich, H. M., & Prell, T. (2020). What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?. Frontiers in medicine, 7, 103. https://doi.org/10.3389/fmed.2020.00103
Eggers, C., Wolz, M., Warnecke, T., Prell, T., & Tönges, L. (2020). Parkinson-Netzwerke in Deutschland: Zukunft oder Utopie? [Parkinson Networks in Germany: Future or Utopia?]. Fortschritte der Neurologie-Psychiatrie, 88(9), 586–589. https://doi.org/10.1055/a-1113-7751
Zipprich, H. M., Arends, M. C., Schumacher, U., Bahr, V., Scherag, A., Kwetkat, A., Wedding, U., Brunkhorst, F. M., Witte, O. W., Prell, T., & Redecker, C. (2020). Outcome of Older Patients with Acute Neuropsychological Symptoms Not Fulfilling Criteria of Delirium. Journal of the American Geriatrics Society, 68(7), 1469–1475. https://doi.org/10.1111/jgs.16422
Prell, T., Schaller, D., Perner, C., Witte, O. W., & Grosskreutz, J. (2020). Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life. Parkinson's disease, 2020, 2958635. https://doi.org/10.1155/2020/2958635
Steinbach, R., Batyrbekova, M., Gaur, N., Voss, A., Stubendorff, B., Mayer, T. E., Gaser, C., Witte, O. W., Prell, T., & Grosskreutz, J. (2020). Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. NeuroImage. Clinical, 25, 102094. https://doi.org/10.1016/j.nicl.2019.102094
Gottschling, J., Dörendahl, J., Prell, T., Karbach, J., Bunz, M., Kindermann, I., Moussaoui, J., Spinath, F. M., Wedegärtner, S., Witte, O. W., Greiff, S., & Segal, D. L. (2020). Measuring Anxiety in Older Adults: Development, Diagnostic Accuracy, and Preliminary Validation of a Short-Form of the German Geriatric Anxiety Scale (GAS-G-SF). Journal of personality assessment, 102(2), 196–204. https://doi.org/10.1080/00223891.2019.1677679
Prell, T., Witte, O. W., Gunkel, A., & Grosskreutz, J. (2020). Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis. Aging & mental health, 24(12), 1963–1967. https://doi.org/10.1080/13607863.2019.1642296
Prell, T., Steinbach, R., Witte, O. W., & Grosskreutz, J. (2019). Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis. eNeurologicalSci, 16, 100198. https://doi.org/10.1016/j.ensci.2019.100198
Heimrich, K. G., Jacob, V. Y. P., Schaller, D., Stallmach, A., Witte, O. W., & Prell, T. (2019). Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells. NPJ Parkinson's disease, 5, 15. https://doi.org/10.1038/s41531-019-0087-3
Prell, T., Grosskreutz, J., Mendorf, S., Witte, O. W., & Kunze, A. (2019). Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS). Data in brief, 23, 103855. https://doi.org/10.1016/j.dib.2019.103855
Prell T. (2019). Adherence to medication in neurogeriatric patients: an observational cross-sectional study. BMC public health, 19(1), 1012. https://doi.org/10.1186/s12889-019-7353-5
Warnecke, T., Dziewas, R., Wirth, R., Bauer, J. M., & Prell, T. (2019). Dysphagia from a neurogeriatric point of view : Pathogenesis, diagnosis and management. Dysphagie aus neurogeriatrischer Sicht : Pathogenese, Diagnostik und Management. Zeitschrift fur Gerontologie und Geriatrie, 52(4), 330–335. https://doi.org/10.1007/s00391-019-01563-x
Perner, C., Perner, F., Gaur, N., Zimmermann, S., Witte, O. W., Heidel, F. H., Grosskreutz, J., & Prell, T. (2019). Plasma VCAM1 levels correlate with disease severity in Parkinson's disease. Journal of neuroinflammation, 16(1), 94. https://doi.org/10.1186/s12974-019-1482-8
Brodoehl, S., Wagner, F., Prell, T., Klingner, C., Witte, O. W., & Günther, A. (2019). Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment. NeuroImage. Clinical, 22, 101792. https://doi.org/10.1016/j.nicl.2019.101792
Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease. Frontiers in neurology, 10, 195. https://doi.org/10.3389/fneur.2019.00195
Prell, T., Grosskreutz, J., Mendorf, S., Franke, G. H., Witte, O. W., & Kunze, A. (2019). Clusters of non-adherence to medication in neurological patients. Research in social & administrative pharmacy, 15(12), 1419–1424. https://doi.org/10.1016/j.sapharm.2019.01.001
Prell, T., Stubendorff, B., Le, T. T., Gaur, N., Tadić, V., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging. Frontiers in aging neuroscience, 11, 5. https://doi.org/10.3389/fnagi.2019.00005
Prell, T., Schaller, D., Perner, C., Franke, G. H., Witte, O. W., Kunze, A., & Grosskreutz, J. (2019). Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson's disease. Patient preference and adherence, 13, 151–155. https://doi.org/10.2147/PPA.S186732
Prell, T., Dirks, M., Arvanitis, D., Braun, D., Peschel, T., Worthmann, H., Schuppner, R., Raab, P., Grosskreutz, J., & Weissenborn, K. (2019). Cerebral patterns of neuropsychological disturbances in hepatitis C patients. Journal of neurovirology, 25(2), 229–238. https://doi.org/10.1007/s13365-018-0709-2
Prell, T., Gaur, N., Stubendorff, B., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. Journal of the neurological sciences, 397, 92–95. https://doi.org/10.1016/j.jns.2018.12.035
Sengupta, S., Le, T. T., Adam, A., Tadić, V., Stubendorff, B., Keiner, S., Kloss, L., Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice. The European journal of neuroscience, 49(1), 62–78. https://doi.org/10.1111/ejn.14276
Prell, T., Steinbach, R., Witte, O. W., & Grosskreutz, J. (2019). Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis. eNeurologicalSci, 16, 100198. https://doi.org/10.1016/j.ensci.2019.100198
Heimrich, K. G., Jacob, V. Y. P., Schaller, D., Stallmach, A., Witte, O. W., & Prell, T. (2019). Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells. NPJ Parkinson's disease, 5, 15. https://doi.org/10.1038/s41531-019-0087-3
Prell, T., Grosskreutz, J., Mendorf, S., Witte, O. W., & Kunze, A. (2019). Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS). Data in brief, 23, 103855. https://doi.org/10.1016/j.dib.2019.103855
Prell T. (2019). Adherence to medication in neurogeriatric patients: an observational cross-sectional study. BMC public health, 19(1), 1012. https://doi.org/10.1186/s12889-019-7353-5
Warnecke, T., Dziewas, R., Wirth, R., Bauer, J. M., & Prell, T. (2019). Dysphagia from a neurogeriatric point of view : Pathogenesis, diagnosis and management. Dysphagie aus neurogeriatrischer Sicht : Pathogenese, Diagnostik und Management. Zeitschrift fur Gerontologie und Geriatrie, 52(4), 330–335. https://doi.org/10.1007/s00391-019-01563-x
Perner, C., Perner, F., Gaur, N., Zimmermann, S., Witte, O. W., Heidel, F. H., Grosskreutz, J., & Prell, T. (2019). Plasma VCAM1 levels correlate with disease severity in Parkinson's disease. Journal of neuroinflammation, 16(1), 94. https://doi.org/10.1186/s12974-019-1482-8
Brodoehl, S., Wagner, F., Prell, T., Klingner, C., Witte, O. W., & Günther, A. (2019). Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment. NeuroImage. Clinical, 22, 101792. https://doi.org/10.1016/j.nicl.2019.101792
Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease. Frontiers in neurology, 10, 195. https://doi.org/10.3389/fneur.2019.00195
Prell, T., Grosskreutz, J., Mendorf, S., Franke, G. H., Witte, O. W., & Kunze, A. (2019). Clusters of non-adherence to medication in neurological patients. Research in social & administrative pharmacy, 15(12), 1419–1424. https://doi.org/10.1016/j.sapharm.2019.01.001
Prell, T., Stubendorff, B., Le, T. T., Gaur, N., Tadić, V., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging. Frontiers in aging neuroscience, 11, 5. https://doi.org/10.3389/fnagi.2019.00005
Prell, T., Schaller, D., Perner, C., Franke, G. H., Witte, O. W., Kunze, A., & Grosskreutz, J. (2019). Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson's disease. Patient preference and adherence, 13, 151–155. https://doi.org/10.2147/PPA.S186732
Prell, T., Dirks, M., Arvanitis, D., Braun, D., Peschel, T., Worthmann, H., Schuppner, R., Raab, P., Grosskreutz, J., & Weissenborn, K. (2019). Cerebral patterns of neuropsychological disturbances in hepatitis C patients. Journal of neurovirology, 25(2), 229–238. https://doi.org/10.1007/s13365-018-0709-2
Prell, T., Gaur, N., Stubendorff, B., Rödiger, A., Witte, O. W., & Grosskreutz, J. (2019). Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. Journal of the neurological sciences, 397, 92–95. https://doi.org/10.1016/j.jns.2018.12.035
Sengupta, S., Le, T. T., Adam, A., Tadić, V., Stubendorff, B., Keiner, S., Kloss, L., Prell, T., Witte, O. W., & Grosskreutz, J. (2019). Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice. The European journal of neuroscience, 49(1), 62–78. https://doi.org/10.1111/ejn.14276